Although venous thromboem-bolism is a common disease,underlying pathogenic mech-anisms are only partially known, particularly in comparison to those of atherothrombosis. During the past decades, progress has been made in the identification and characterization of the cellular and molecular mecha-nisms that interdependently influence Virchow’s triad. It is now accepted that the combination of stasis and hyperco-agulability, much more than endothelial damage and activation, are crucial for the occurrence of venous thrombosis; venous thrombi are mainly constituted by fibrin and red blood cell, and less by platelets. In contrast, platelets are essential for pri
Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries, especia...
Atherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets a...
Atherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets a...
An association between the risk of venous throm-boembolism and a hypercoagulable state has beenrecog...
This editorial refers to ‘A prospective study on cardio-vascular events after acute pulmonary emboli...
Venous thromboembolism (VTE) is a multifactorial disease. Major provoking factors (e. g. surgery, ca...
Haemostasis and thrombosis are complex, multifactorial processes. There is an evolving understanding...
P>Epidemiological research throughout the last 50 years has provided the long list of risk factor...
The pathogenesis of arterial thrombosis is complex and dynamic. Unlike venous thrombi, arterial thro...
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE...
Thrombo-inflammation describes the complex interplay between blood coagulation and inflammation that...
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow des...
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow des...
Venous thromboembolism (VTE) is the third leading cardiovascular cause of death and is conventionall...
An update of Virchow's triad for thrombogenesis can be considered by reference to abnormalities...
Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries, especia...
Atherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets a...
Atherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets a...
An association between the risk of venous throm-boembolism and a hypercoagulable state has beenrecog...
This editorial refers to ‘A prospective study on cardio-vascular events after acute pulmonary emboli...
Venous thromboembolism (VTE) is a multifactorial disease. Major provoking factors (e. g. surgery, ca...
Haemostasis and thrombosis are complex, multifactorial processes. There is an evolving understanding...
P>Epidemiological research throughout the last 50 years has provided the long list of risk factor...
The pathogenesis of arterial thrombosis is complex and dynamic. Unlike venous thrombi, arterial thro...
Venous thromboembolism (VTE) is the third most common cause of death worldwide. The incidence of VTE...
Thrombo-inflammation describes the complex interplay between blood coagulation and inflammation that...
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow des...
Venous thromboembolism (VTE) has been a subject of great interest of late. Since Rudolph Virchow des...
Venous thromboembolism (VTE) is the third leading cardiovascular cause of death and is conventionall...
An update of Virchow's triad for thrombogenesis can be considered by reference to abnormalities...
Venous thrombosis is a leading cause of morbidity and mortality in industrialized countries, especia...
Atherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets a...
Atherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets a...